tVNS for epilepsy

The short version

If you or someone you care for has epilepsy that has not fully responded to medication, tVNS is a non-invasive option worth knowing about. It is a small unit with an electrode worn in the ear that delivers gentle electrical impulses to a branch of the vagus nerve. The goal is to reduce how often seizures happen. It is used alongside your usual anti-seizure medicines, never as a replacement. You can use it at home.

The tVNS device is a certified medical device, manufactured in Germany and distributed in the UK by Anatomical Concepts UK. If you are curious whether it could help you, read on.

What we are trying to solve

Around one in a hundred people in the UK live with epilepsy. For about two-thirds of them, medication brings seizures under reasonable control. For the remaining third, the drugs do not work well enough. Clinicians call this drug-resistant epilepsy. If you are in that group, you already know how difficult it can be. Seizures affect almost every aspect of daily life: driving, work, confidence, sleep, and relationships.

Surgery is sometimes an option, but not everyone is suitable for it, and not everyone wants it. For decades, an implanted device called a vagus nerve stimulator (VNS) has been offered to people with drug-resistant epilepsy, but it too requires surgery, under general anaesthetic, to place the stimulator under the skin of the neck.

tVNS is the non-invasive version of the same idea.

How it works, in plain English

The vagus nerve is one of the longest nerves in the body. It runs from the base of the brain, through the neck, and branches out to the heart, lungs, gut, and other organs. One small branch of it, called the auricular branch, emerges in the outer ear on a small ridge called the cymba conchae.

The tVNS device clips into the ear and touches this ridge. When you switch it on, it sends tiny, rhythmic electrical pulses into that branch. Those pulses travel up the vagus nerve to the brainstem and from there to brain regions involved in seizures. Over time, this appears to make seizures less likely to happen and, when they do happen, often less severe.

You do not feel anything dramatic. Most people describe a gentle tingling in the ear. You wear the device for a few hours a day, sitting, working, reading, or relaxing. You do not need to stop what you are doing.

What the evidence shows

tVNS is not a cure for epilepsy. Nothing is, for most people. But the research now supports its use as an add-on treatment for drug-resistant epilepsy, and the picture has strengthened considerably in the last few years.

In the largest controlled trial to date, published in 2023, just under 45% of people using tVNS achieved at least a 50% reduction in the number of their seizures, compared with around 17% in the control group.
In a real-world study that followed participants for 1 to 2 years, over 60% achieved at least a 50% reduction.
The benefit tends to build up over time. Most studies show the clearest improvement around 20 weeks, so this is not a quick fix. It asks for patience.
Most side effects are mild and local: tingling, itching, or redness where the electrode sits, and sometimes headache, dizziness, or ear or neck discomfort. As with any vagus nerve therapy, some people notice a temporary increase in seizures early on. The Instructions for Use list the full range of possible effects, and you should tell your clinician about anything that concerns you.

It is worth saying clearly: not everyone responds. The research suggests that people with fewer seizures to begin with tend to respond better, and that focal seizures may respond slightly better than some other types. Your clinician is the best person to say whether you are likely to be a good candidate.

What to expect

Here is what a typical tVNS treatment looks like in practice.

You keep taking your current medicines. tVNS is an add-on, not a replacement. Your consultant sets the starting conditions.
You use the device at home for a few hours each day. You can split this into shorter sessions if that fits your day better.
You keep a seizure diary. This is important. You and your clinician need good information to judge whether the treatment is working.
You wait, and you persist. The first real signs of benefit often take twelve weeks to emerge. Clearer evidence of response often takes twenty weeks or longer.
You review with your clinician. At eight, twelve, and twenty weeks, you sit down with your neurologist or specialist nurse and look at the diary together. If the device is working, you continue. If not, you and your clinician decide what to try next.

A note on patience. This is a point we make often about any form of neuromodulation: the brain does not change overnight. The results that matter come from consistent daily use over months, not from dramatic weekly improvements.

Who it is not for

tVNS is intended for adults aged 18 and over, and it is generally well tolerated, but there are some situations where it is not suitable. Do not use tVNS if you:

are pregnant
have an active implant, such as a cochlear implant, an implanted vagus nerve stimulator, or a cardiac pacemaker
have a cerebral shunt (for example, for hydrocephalus)
have sore or broken skin where the electrode would sit

If you have a heart rhythm problem, talk to your doctor before using tVNS. Your clinician will check all of this before recommending it, and tVNS should be used under medical supervision. If you are ever unsure, ask us or ask your consultant.

Common questions

Is tVNS the same as the implanted vagus nerve stimulator? No. The implanted VNS is a stimulator placed surgically under the skin of the neck, with a wire wrapped around the vagus nerve. It has a longer track record, and some studies show slightly higher response rates. tVNS delivers a similar idea, from the outside, through the ear. No surgery, no implant, and it can be stopped at any time.

Does it hurt? Most people describe a mild tingling feeling in the ear. It should not be painful. The device is set just below your pain threshold so that you feel it clearly but never uncomfortably.

Can I still drive? Driving depends on your seizure control, not on the device itself. DVLA rules apply to you in the usual way. Your consultant is the right person to advise you on driving.

Can I use it with other treatments? Yes. tVNS is designed to be used alongside your existing medication. Many people use it while also continuing other therapies. Always talk to your consultant first.

How much does it cost? The tVNS device is considerably less expensive than the implanted version. You can find current pricing on the device page. If cost is a barrier, contact us and we can talk through options.

What to do next

If you are considering tVNS for epilepsy, here are three sensible next steps.

Talk to your neurologist or specialist. Ask whether they are open to neuromodulation as an add-on to your current treatment. If they want more information, we can speak to them directly.
Read the clinicians' page if you want a deeper dive into the evidence, the dosing parameters, and the mechanisms. It is written for healthcare professionals but the curious and determined patient often gets a lot from it too.
Contact us. If you have specific questions about whether tVNS might be right for you, call or email. We will give you a straight answer, including whether we think tVNS is unlikely to help.

Contact Anatomical Concepts UK

For clinicians: the full evidence page

How to access tVNS

This page is for information only. It is not medical advice. Any decision about tVNS should be made with your clinician, who knows your full medical history.

tVNS is a Class IIa medical device manufactured by tVNS Technologies GmbH, Germany. Distributed in the UK by Anatomical Concepts UK Ltd.